Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Clasificación en acciones #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Precio por acción
$41.14
Última sincronización: 2026-09-21
Capitalización bursátil
$182.76B
Cambio (1 día)
-7.78%
Cambio (1 año)
-32.24%
País
DK
Comercio Novo Nordisk A/S (NOVO-B)

Categoría

Ratio P/B de Novo Nordisk A/S (NOVO-B)
Ratio P/B al September 2026 TTM: 5.61
Según los informes financieros más recientes y el precio de las acciones de Novo Nordisk A/S, el ratio P/B actual (TTM) es 5.61. Al final de 2024, el ratio P/B era 19.38.
Historial del ratio P/B de Novo Nordisk A/S desde 2000 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 5.61 -24.68%
2025 7.45 -61.56%
2024 19.38 -34.02%
2023 29.37 15.39%
2022 25.45 6.65%
2021 23.87 51.77%
2020 15.72 -1.35%
2019 15.94 12.22%
2018 14.20 -14.34%
2017 16.58 16.48%
2016 14.23 -34.97%
2015 21.89 29.23%
2014 16.94 35.36%
2013 12.51 -0.67%
2012 12.60 26.42%
2011 9.97 0.88%
2010 9.88 77.44%
2009 5.57 9.91%
2008 5.07 -20.41%
2007 6.36 25.26%
2006 5.08 20.40%
2005 4.22 11.39%
2004 3.79 16.59%
2003 3.25 4.96%
2002 3.10 -47.14%
2001 5.86 -4.54%
2000 6.14 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
29.9692 434.10%
US
7.6479 36.30%
US
-78.0908 -1,491.70%
US
8.4776 51.08%
CH
8.5385 52.17%
US